Offerings / Regulation CF / Normopharm Inc
Normopharm Inc
Regulation Crowdfunding offering on Wefunder · Form C filed June 23, 2026 · Dover, Delaware
SAFEEarly revenueCorporation, Delaware
Business summary pending extraction from the offering statement. The company is a corporation organized in Delaware on November 19, 2018, based in Dover, DE, with 2 employees and $98,467 of revenue in its most recent fiscal year.
Offering terms
- Security
- Simple Agreement for Future Equity (SAFE)
- Maximum
- $124,000.00
- Price
- $1.00 per unit
- Pricing method
- Pro-rated portion of the total principal value of $50,000; interests will be sold in increments of $1; each investment is convertible to one share of stock as described under Item 13.
- Deadline
- April 30, 2027
- Oversubscriptions
- Accepted
- Intermediary
- Wefunder Portal LLC
Funding portal, SEC file 007-00033 - Intermediary fee
- 7.9% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.
- Intermediary equity
- No
- Co-issuer
- Normopharm I, a series of Wefunder SPV, LLC
Financials as filed
| Item | Most recent FY | Prior FY |
|---|---|---|
| Revenue | $98,467 | $38,300 |
| Cost of goods sold | $75,636 | $51,288 |
| Net income (loss) | -$188,654 | -$107,330 |
| Total assets | $35,065 | $42,834 |
| Cash and equivalents | $13,526 | $11,851 |
| Accounts receivable | $0 | $0 |
| Short-term debt | $0 | $0 |
| Long-term debt | $269,300 | $99,650 |
| Taxes paid | $0 | $0 |
Two fiscal years as reported on the Form C cover sheet. 2 employees. Offered in 56 states.